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Neuropeptides are important neurotransmitters in nasal
physiology and the increasing knowledge of their role in
nasal diseases brings new therapeutic perspectives. The
investigation of human nasal mucosa neuropeptides is based
mostly on immunocytochemistry, a complex approach
whose resulting factors may be variable. Aiming to make
this kind of research available, an immunofluorescence
approach for vasoactive intestinal peptide (VIP) in human
nasal mucosa is proposed and evaluated. Study design:
Transversal cohort. Material and Method: Human inferior
turbinate samples were obtained at time of nasal surgery
from eight patients. The samples were fixed in Zamboni
solution (4% phosphate-buffered paraformaldehyde and
0.4% picric acid), snap-frozen and stored at -70ºC. 14 µm
sections were then obtained. Immunofluorescence staining
for VIP (Peninsula Laboratories) was performed and its images
documented by conventional photography. The method’s
specificity, sensitivity and reproducibility of execution were
evaluated. Additionally, the reproducibility of interpretation
of results was evaluated through the comparison of staining
scores (0 to 4) attributed to the images by six observers.
Results: The results showed the approach to be very specific
and sensible, besides being reproducible in its execution.
The interpretation of results may depend on the observer’s
accuracy in judging immunofluorescence images, but it
showed uniformity. Conclusion: The proposed method
was highly useful for research purposes in neuropeptides in
human nasal mucosa.
Key words: vasoactive intestinal peptide, neuropeptides,
nasal mucosa, immunofluorescence.
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INTRODUCTION
The role of nose in protecting the airways, through
its classical functions of filtration, heating and humidification
of inhaled air, is effective thanks to the peculiar anatomy of
the nasal cavity and functional aspects of the lining mucosa.
The capability to widely vary its volume, modifying the air
resistance by congesting venous plexus, in addition to large
variations of gland secretion according to exogenous and
endogenous factors, are intriguing phenomena of the nasal
physiology that are continuously studied 1. The role of
abundant sympathetic, parasympathetic and sensitive
innervation in the control of these phenomena is extremely
important 2.
The balance of classical neurotransmitters, acetylcholine
and noradrenalin, present in sympathetic and parasympathetic
innervation - and sometimes in their imbalance - have been
predominant in the explanation of nasal physiological and
pathological phenomena, and they have guided the
therapeutic principles of nasal pathological conditions.
Together with sympathetic and parasympathetic innervation,
sensitive innervation has a significant physiological role in the
protection reflex of airways, regulating the blood flow and
consequently, the nasal air resistance, glandular secretion, and
also mediating inflammatory and allergic responses 2,3.
The discovery and study of new neurotransmitters,
the neuropeptides, in different animal tissues and also in
human beings have brought to light new concepts about
physiology of innervation of these organs. There are dozens
of neuropeptides already being studied, and the respiratory
system is widely investigated 4.
Neuropeptides coexist with classical neurotransmitters,
playing a key role in modulation. Generically, the
neuropeptide action is more subtle, but it is long-lasting, in
addition to the interaction with cells and allergic and
inflammatory mediators, which have a more complex
function when compared to classical neurotransmitters, which
impact the study of nasal physiology and pathophysiology.
Considering the neuropeptides, substance P (SP), neurokinin
A and B (NKA and NKB), calcitonin gene related peptide
(CGRP), gastrin release peptide (GRP), vasoactive intesti-
nal peptide (VIP), peptide histidin methyonine (PHM) and
neuropeptide Y (NPY) have been studied in the respiratory
system 5.
Therefore, the demonstration of these neuropeptides
in human nasal mucosa concerning their presence, epithelial
distribution and lamina propria structures, in addition to
differences between normal and pathological conditions, has
been the object of research and brought light to deep
understanding of nasal physiology and pathophysiology 2, 6.
The progression of this knowledge may point towards new
alternatives for nasal disease treatment in the near future,
thanks to the development of antagonists, considering that
there are already some results in central nervous system 7.
However, so that it may become a fact, we need to have
concepts and conclusions based on studies with large samples
and preferably, coming from different universally distributed
research centers. Only then we will be able to define facts
about the actions of neuropeptides in human nasal mucosa
that can really reflect clinical practice applications. The
methodology used in the study of neurotransmitters
concerning presence and distribution of tissues is normally
based on immunelabeling, which is a complex technique that
has variations and is relatively expensive. The identification
of neuropeptides brings special technical difficulties owing to
the fragility of molecular structure and easy degranulation and
elimination of nervous fibers, suffering the action of proteolytic
enzymes, requiring a detailed technique, from collection of
tissue to be studied to its processing 8. All neuropeptides
listed here are located inside nervous fibers that are distributed
in the human nasal mucosa, so as that when they are identified
by immunelabeling, they can delineate the fiber they contain
9. The fact that neuropeptides belong to a specific molecular
class and share physiological similarities allows the use of a
common technique of identification concerning aspects of
tissue manipulation, reaction of immunelabeling and
observation of results, ranging exclusively from neuropeptide
specific antibodies in question (primary antibody), which is
provided by reaction kits. In this study, we conducted
immunofluorescence reaction for VIP, which is one of the
most important neuropeptides, present in nervous fibers that
are distributed on the lamina propria of human nasal mucosa
6, 10. There are no studies on immunelabeling of neuropeptides
on the human nasal mucosa published in our country. Thus,
our paper intended to find the domain and standardization of
an immunofluorescence technique for human nasal mucosa
neuropeptides, providing an important investigation method
to be reproduced and uniformly interpreted to support further
investigations in nasal physiology and pathophysiology.
LITERATURE REVIEW
Neuropeptides
Neuropeptides are neurotransmitters present in
neurons and nervous fibers spread throughout the whole
body, also found in experimental animal models. They are
peptides, or sequence of amino acids synthesized in cell
bodies and transported to axon endings. When classical
neurotransmitters are released, they demonstrate some
differences: they are released in regions not-exclusively
synaptic, suffer enzymatic degradation after release, not used
for reuptake, renovation takes place exclusively by synthesis
of cell body, and it is a slower process compared to classical
neurotransmitters, which can be recaptured in synaptic chink
and immediately reused 4.
In the nasal mucosa, SP, together with NKA, NKB and
CGRP, form the group of sensorial neuropeptides abundantly
found in cell bodies of trigeminal ganglion and nasal mucosa
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of animals and humans, distributed from the epithelium to
glands and vessels 11. They are vasodilators, and SP is the
most powerful and CGRP has the longest effect 12.
SP promotes increase in vascular permeability, leading
to increase in concentration of proteins in nasal secretion 13.
This effect is exacerbated in patients with seasonal allergic
rhinitis and it is not reduced with previous treatment with
anti-histaminic, leading authors to conclude that SP effects
would be independent from histamine release 14. In a culture
of human nasal mucosa cells, however, other authors
confirmed the release of histamine based on the stimulation
of SP 15.
SP can have chemotaxic effect over neutrophils
and eosinophils in subjects with allergic rhinitis, because
there is increase in migration of cells and phagocytosis of
nasal mucosa after administration of SP in periods of
pollenization 5.
Other significant action of SP and NKA in respiratory
system is non-cholinergic bronchoconstriction. In humans,
inhalation of SP and NKA causes bronchoconstriction only in
asthmatic subjects, eliminated by sodium chromoglycate 16.
GRP is a peptide found in nervous fibers and
distributed on nasal mucosa similarly to SP, NKA and CGRP,
probably in sensitive fibers, referred together with these
neuropeptides, but its location is still unknown. The action
seems to be related with secretion and not vascular
phenomena 10.
The main neuropeptide of parasympathetic
innervation is VIP, found in sphenopalatine ganglion of rats
and parasympathetic fibers that are distributed in nasal
mucosa of animals and humans, coexisting with acetylcholine
5, 17. VIP has vasodilating action observed in in vivo
experiments in nasal mucosa of animals. In humans, there
are in vitro experiments that demonstrated its vasodilating
action in pulmonary tissue 17.
Its presence in nervous fibers around the glands
especially refers to the physiology of secretion. In the culture
of human nasal mucosa cells, the increase of serous cell
secretion after administration of VIP was observed, in addition
to evidence of maximization of effect of cholinergic
stimulation 18, but there are studies that demonstrated
secretion inhibitory action 10.
We observed increase in concentration of VIP (in
addition to SP and CGRP) in nasal secretion of allergic subjects
sensitized after nasal provocation. The same authors also
confirmed increase in VIP after administration of histamine
19. There was higher density of immunereactive fibers to
VIP in patients with allergic rhinitis when compared to nor-
mal subjects or those with hypertrophic rhinitis 3.
NPY is present in sympathetic nervous terminations
that are distributed in the respiratory system, including
humans’ nasal mucosa, coexisting with noradrenalin, with
great density in thicker-wall vessels. NPY is a powerful
vasoconstrictor, its action has more latency at first, but it is
more long-lasting than noradrenalin. These findings suggest
a significant role in control of blood nasal flow and nasal
cycle 10.
Immunelabeling of neuropeptides
Immune, immunecytokine or immunohistochemical
labeling is a method of location of an antigen that forms cell
or tissue, using labeled antibodies, based on high affinity
and specificity that characterizes the antigen-antibody reaction
8. Depending on the type of marker linked to the antibody,
the method is specifically named, such as for example:
fluorescent markers - immunofluorescence; enzymatic
markers such as peroxidase - immuneperoxidase.
Fluorescent markers, such as fluorescein isothiocyanide
(FITC) were the first ones to be used; to visualize it, dark
field microscope with appropriate filters are required. FITC,
when excited by 490 nm wavelength, generates light green
fluorescence 20. One of the uses of immunofluorescence is
location of nervous fiber neuropeptides, and in thick sections,
with appropriate fixation, it allows the observation of sinuous
fiber through the studied tissue 9.
A disadvantage of immunofluorescence is that labeling
is not permanent, because most of the markers tend to lose
fluorescence with time, especially under the action of light
8.
Tissues fixed in formalin tend to be auto-fluorescent
and if they contain catecholamines, they may be induced
and generate specific fluorescence colored close to
fluorescein 21.
Neuropeptides may suffer degranulation and
elimination of fibers by chemical and mechanical stimuli.
The technique for collection of fragment could influence
the presence of neuropeptides by the use of topical
medication (anesthetics and vasoconstrictors) and by
mechanical manipulation, influencing the results of
immunofluorescence 5. The collection of nasal mucosa from
inferior and medium concha is referred in the literature
without technical details 2, 3, 6, 22.
The method of tissue fixation is crucial for the success
of immunelabeling. There is not an ideal method because
both antigen and tissue require a specific type of fixation.
Good preservation of the architecture of the tissue allows
that the antigen be located in its biological context, and it is
one of the main characteristics that mark the relevance of
the immunelabeling method 8.
There are two types of fixation solutions more
frequently used in the preparation of histology slides:
aldehydes, which promote food tissue preservation but may
affect the antigen-capacity of peptides by
immunofluorescence, and precipitates, that affect less the
antigen structure of peptides, but may not manage to
prevent dispersion 23.
Immunofluorescence, with mixed fixation solutions,
such as Zamboni solution (picric acid and buffered
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paraformaldehyde) are indicated because they balance these
aspects 24.
pH, fixation time and temperature may also influence
the grade of tissue fixation and may impair antigenicity of
peptides 25, and many literature studies reported variation
in these technical aspects 2,3,6,22.
The tissue may be fresh frozen, or in other words,
without fixation process to conduct immunofluorescence,
but the structure is not well preserved when compared to
material with fixation. Conversely, the problems presented
by the fixing solutions are solved.
However, manipulation of tissue not previously fixated
require care, because the constituent proteins have higher
chances of being spread 8. Regardless, immediate fixation
or tissue freezing before proteins are solubilized during
decomposition process is essential for the objectives of
immunelabeling 23.
Ideal storage for immunofluorescence is freezing,
because the inclusion in paraffin forms a barrier against
penetration of antibodies 26. The freezing technique, storage
temperature and thickness of cryostat sections range in studies
that described immunofluorescence for neuropeptides in
human nasal mucosa 2,3,6,22.
The frozen specimen, if excessively dried, may hinder
cryostat section, and we should be careful when storing it to
eliminate air from neighboring tissues 25.
The preparation of slides require cure concerning
compliance to section. There are commercially available kits
to this purpose, and previously prepared slides. For
immunofluorescence applications, these elements are
important because of the long reaction and exposure to
rinsing 8.
The documentation of slides using microscopic
photography presents some difficulties concerning instability
of fluorescence 8.
Immunofluorescence serves primarily for qualitative
information. However, some authors developed methods
for its quantification, automated or not, that may allow
comparisons 3,6,22.
Once checked the importance of neuropeptides in
human nasal mucosa and complexity and variability of
immunofluorescence techniques in study, the purpose of
the present study was to study an immunofluorescence
technique to VIP to analyze its application for research
purposes.
MATERIAL AND METHOD
We collected nasal mucosa fragments of 8 patients
submitted to nasal surgeries for nasal obstructions:
septoplasty, turbinectomy and rhinoseptoplasty. The present
study was approved by the Research Ethics Permanent
Committee for Studies in Human Beings, State University of
Maringá.
Authorization for the collection of material in the
informed consent term was signed by the patients or
responsible person.
We excluded patients that had high surgical or
anesthetic risks.
There was no minimum or maximum age for inclusion.
Patients were instructed to interrupt antiinflammatory,
hormonal or non-hormonal medication use, in addition to
anti-histamine, systemic or topical, or any other drug or
substance that could have influenced the results at least one
week before the procedure, provided that there were no
contraindication for their suspension. After collection, we
performed the surgical procedure, whose technique and
dressing did not differ from routine procedures.
Postoperative follow-up, care and drugs did not in-
terfere in the habitual routine for this type of surgery.
Fragments were collected without nasal mucosa
infiltration, but with topical vasoconstriction with adrenalin
1:10,000 for 5 minutes, with patients submitted to general
anesthesia, without use of inhalation induction. Similarly, we
tried to avoid excessive manipulation in the collection, which
was facilitated by topical vasoconstriction and minimization
of bleeding. We collected a fragment of inferior nasal con-
cha from each patient, measuring about 1.0cm from its an-
terior extremity, 1 to 2.0cm long by 0.3 to 1.0cm width and
variable thickness on the side that presented easy access.
Next, we describe the fixation procedures and storage:
Immediate fixation in Zamboni solution
(paraformaldehyde 4% and picric acid 0.4% in phosphate
buffer), for 6 hours at 4ºC; repetitive rising with saline buffered
phosphate 0.1 M pH 7.4 (PBS), for 12 hours; cryoprotection
in solutions of sucrose 18% in PBS 0.1M, for 24 hours; freezing
in liquid nitrogen, after they had been soaked in frozen tissue
liquid solution (O.C.T. 4583 compound - Tissue-Tek); stored
in the freezer at -70ºC. Later, we made serial sections of
14µm with cryostat and placed them on previously prepared
slides with organocylane adhesive 2% in ketone and stored
at -1ºC. To observe histology structure of nasal mucosa and
preservation of tissues through the fixation method used,
from each of the four sections for immunofluorescence we
collected two sections for hematoxylin-eosin staining (HE).
For each fragment of nasal mucosa collected, we finally had
eight sections for immunofluorescence and four for HE.
Sections for immunofluorescence were placed on two slides,
totaling 16 at the end.
Immunofluorescence
To perform the technique, we acquired a kit for
immunofluorescence for VIP: Immunofluorescence kit for
VIP (human, porcine, rat) Peninsula Laboratories, code PENI
- IFK7161.
Reactions were performed in two sessions, with four
cases each, in different weeks. Next, we can see the steps
of reactions:
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Day 1:
Slides were brought to room temperature and rinsed
for 3 times, during 10 minutes each, with phosphate buffer
saline (PBS) 0.1M, then washed; we applied 200µl of goat
serum (1: 10) over the slides, and they were incubated at
room temperature for 30 minutes in cold chamber. Slides
were rinsed and we applied 200µl primary antibody (1: 200)
or negative control and slides were incubated at 4ºC for 24
hours in the same chamber.
Day 2:
We made three 10-minute rinses each with PBS 0.1M;
slides were washed and excessive moist was dried with
absorbent towel. We applied 200 µl secondary antibody (1:
100), slides were incubated at room temperature for 60
minutes in the same chamber. We performed 3 washes for
10 minutes with PBS 0.1M; slides were washed and the
excess was dried with absorbent paper; slides were mounted
on laminula and glycerin in PBS (9: 1).
In all steps, we prevented slide drying and tissue
touching.
Slides were observed under dark field photomicroscopy
with epi-illumination (Zeiss axioscan) with 490nm wavelength
filter coupled to conventional photography camera. We
executed photographic documentation of fields that presented
different levels of marking (see below), enlarged 20 and 40
times, with exposure time of 30 or 60 seconds, depending
on field light intensity. We used Pro-Image 100 film by Kodak.
Upon developing it, photos were darkened so that images
could look like the visualization under microscopy; however,
it was not a pre-condition for appropriate assessment of
photos.
Assessment of the Technique
As to specificity: an extra slide of one of the cases
was used as negative control, by omission of primary
antibody.
The slide was blindly assessed by the author and the
observer, together with the other slides of three more cases
concerning the presence or not of labeling.
As to sensitivity: the reaction was applied to intestine
of rat in total preparation, tissue with known presence of
fibers and cell bodies containing VIP to test sensitivity of
antibody. The sequence of amino acid of VIP was common
for humans, rats and pigs, and the kit was applied to any of
these species. The slides were assessed by an observer
familiarized with this type of tissue and presence of labeling.
As to reproducibility of performance: the same
technique was maintained from collection and manipulation
of tissues for 8 cases (16 slides). We defined two parameters:
with labeling and without labeling. We assessed the number
of slides that presented labeling and out of the total of slides,
we concluded the reproducibility of the technique.
As to reproducibility in interpretation of results: we
defined standards of labeling grades concerning number of
fibers labeled as follows: grade zero - no fiber in the field;
grade one - rare fibers; grade two - sparse or few fibers;
grade three - numerous fibers; grade four - many fibers. For
each grade, we associated photos of fields to illustrate the
classification (Figures 1 to 4).
The documentation produced photos of random
microscopic fields that illustrated five grades of labeling. The
total number of photos was 171 distributed by seven cases
that presented labeling. The photos of the case in which there
was no labeling were included for analysis. Five observers - A
to E were presented to the examples that illustrated the gra-
des of labeling, oriented towards their meaning and required
to classify photos independently. Three observes were Ph.D.
professors, Department of Morphophysiology Sciences, UEM,
experienced in immunofluorescence in animal tissues and
two were taking post-graduation studies in Pharmaceutical
Sciences, without experience in the topic. The author was
the sixth observer F.
The grades of labeling attributed by the six observers
were compared concerning coincidence or discrepancy of
results using Kruskal-Wallis test for non-dependent variables.
RESULTS
As to specificity: negative control did not show labeling
after blind assessment of 2 observers.
As to sensitivity: the method showed labeling when
applied to total preparation of rat intestine VIP, proving to
be sensitive to VIP.
As to reproducibility of execution: out of 16 slides,
14 showed VIP labeling (87.5%).
As to reproducibility of interpretation of results: gra-
des attributed to photos by the 6 observers were compared
using Kruskal-Wallis test, and it showed that there were
differences among the interpretation of observers (p<0.05).
Observer E differed from A, B and D, but not from C and F
(Table 1). Considering the other five observers, there was
uniformity of interpretation of results.
Distribution of grades attributed to each photo by
the observers can be assessed in Graph 1.
DISCUSSION
The review presented here shows an unquestionable
importance to neuropeptides in human nasal mucosa
concerning physiology and pathophysiology of diseases.
Nasal innervation deeply participates in physiological
phenomena related to reflexes of defense of airways. In
addition to classical neurotransmitters, much has been studied
about neuropeptides. Some of the general characteristics
differentiate them from classical neurotransmitters, among
them the fact that their removal occurs by synthesis at the
level of cell body, and not at reuptake of synaptic chink,
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meaning that their effects are less dramatic 5. Thus, they are
targets for research studies with therapeutic purposes, since
neurotransmitters antagonists with these characteristics tend
to have fewer side effects4.
Both sensorial innervation and sympathetic and
parasympathetic innervation contain neuropeptides in na-
sal mucosa whose actions have been investigated.
Once we confirm the importance of neuropeptides
in nasal physiology and pathophysiology, it is interesting
that this knowledge develops and that concepts are solidified.
Therefore, the higher the number of research studies on the
topic, the faster the knowledge about neuropeptides in
human nasal mucosa could point to new clinical perspectives.
Actions of neuropeptides in respiratory system,
specifically the nasal mucosa, have been studied through in
vivo and in vitro experiments, both in animals and in humans,
as exemplified in the studies that follow.
The presence of neuropeptides in nervous fibers with
morphological fidelity is only performed by using
immunelabeling techniques. Quantitative methods do not
provide morphological information. In turn, immunelabeling
is difficult to quantify, meaning it provides mainly qualitative
information. The investigation of neuropeptides in nasal
mucosa, both quantitative and qualitative, brings information
about nasal physiology and pathophysiology. Comparing
normal subjects and allergic rhinitis patients using these
techniques has added much to the understanding of the
topic 3. Upon proceeding in this field, we were faced by a
considerable barrier from the technical perspective, which
is characterized by the reaction of immunelabeling. The
literature on rhinology shows the methodology in a rather
simplistic way, omitting aspects that we later realized to be
Figure 1. Example of labeling grade 1. Rare fibers identified (arrows).
Artifact (A) and tissue auto-fluorescence (T).
Figure 2. Example of labeling grade 2. Sparse fibers (arrows). Tissue
auto-fluorescence (T) and artifacts (A).
Figure 3. Example of labeling grade 3. Numerous fibers (arrows).
Tissue auto-fluorescence (T) and artifacts (A).
Figure 4. Examples of labeling grade 4. Many fibers (arrows), and it
is possible to follow their pathway intertwined with glandular structures.
More marked tissue auto-fluorescence (T) and artifacts (A).
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important, in addition to many variations in technical details
among the studied papers. From collection of nasal mucosa
we can detect paucity of information in the applied literature.
Some rare authors described the technique, normally simply
alluded as collection 1-3,15,22.
Aspects concerning topical vasoconstriction,
infiltration, luxation of concha and material are not described
as a routine. Since nasal mucosa is an extremely reactive
tissue to stimuli, leading to release of neuropeptides from
its fibers, special attention was given to the collection
procedure during nasal surgery, because it could have
influenced the results. From chemical stimulus, which in
theory would lead to degranulation and elimination of
neuropeptides, we took care to avoid use of anesthetic ga-
ses in mask during induction of general anesthesia 5. After
attempts to collect fragments of nasal mucosa without
vasoconstriction, in an attempt to minimize the stimuli, we
observed that the procedure was hindered by deficit in
visualizing the operation field, because of bleeding, which
could result in excessive mechanical manipulation and
fragmentation of tissue, not desirable in the studied technique.
We came to the conclusion that we should apply
vasoconstriction, in addition to medial luxation of concha.
The collection was made at the beginning of the surgery
and not after it, because excessive manipulation would have
already been made, as well as the need for infiltration.
The fixation methods used, as well as time, also varied
in the literature, and mixed fixation solutions were the most
frequently employed 8, 24. Special attention was directed to
time of fixation, which was longer, despite the better
preservation of the tissue, and the risk of loss of antigenicity,
which in turn, also increased 25. Fixation procedures were
followed according to a study published, with some
adaptations 6: longer time (six hours) to allow complete
penetration of fixation solution and maintenance of 4o C to
limit excessive fixation with risk of loss of antigenicity. Once
we obtained good tissue fixation, confirmed by observation
of slides stained with HE and presence of
immunofluorescence labeling, the fixation method was
considered to be appropriate.
The fact that the tissue presented auto-fluorescence
with the employed fixation solution 21, it allowed
identification of the nasal mucosa components, such as glands
and vessels, creating an advantage.
The ideal storage method for immunelabeling is
freezing 23. We studied different techniques, despite not
detailed, and storage temperatures described in the literature
3, 22. Storage temperature of -70o C was chosen in an attempt
to better preserve the tissue, considering fragility of
neuropeptides.
We also observed freezing with soaked specimen for
section with cryostat, which facilitated the procedure,
sometimes hindered by dryness of tissues.
Table 1. Result of Kruskal-Wallis test demonstrating difference
between interpretation of observer E and interpretations of
observers A, B and D (p<0.05).
A B C D E F
A 1,0000 1,0000 1,0000 0,0043 0,1507
B 1,0000 1,0000 1,0000 0,0459 0,8431
C 1,0000 1,0000 1,0000 0,5085 1,0000
D 1,0000 1,0000 1,0000 0,0204 0,4746
E 0.00433 0.0459 0,5085 0,0204 1,0000
F 0,1507 0, 8 431 1, 0 000 0, 4 746 1, 0 000
Graph 1. Distribution of grades (axis Y) attributed to photos (axis X) for each observer (color points).
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Different thickness is alluded in reference studies on
immunofluorescence. Wider sections, larger than 10µm, allow
follow up of fibers for a longer path, facilitating identification
and making the results more understandable and rich.
Photomicroscopic documentation of nervous fiber
immunofluorescence requires great sensitivity and resolution.
Conventional photography perfectly met these requirements,
given that digital equipment with these characteristics is
extremely expensive.
We noticed differences between the limited vision of
ENT physicians and researchers’ visions, leading to unclear
descriptions, which seemed to have taken an apparently
satisfactory methodology. To confirm this impression, we
proposed a method assessment concerning specificity,
sensitivity, reproducibility of performance and of results’
interpretation.
Results showed that the method is effective
because the negative control did not show labeling.
Immunelabeling is a specific method because it is based
on antigen-antibody reaction. However, knowledge and
familiarity with tissue morphology are required to
interpret the immunofluorescence images of nervous
fibers. We observed background fluorescence and
artifacts by fluorescein debris; any observer not very
involved with the topic may produce too many false-
positive results.
Sensitivity of the laboratory equipment was tested in
positive control of rat intestine, a tissue rich in VIP, including
cell bodies. Once we confirmed efficiency of method in the
tissue, it is reasonable to state that it is sufficiently sensitive
to interpret the results in human nasal mucosa. However,
we can not state that all VIP present in in vivo tissue was
demonstrated by the method, because the different steps
from collection, fixation and storage included factors that
could have led to reduction of its presence (degranulation
and enzymatic degranulation) or to loss of antigenicity. There
is no gold standard to have it compared with.
Reproducibility of execution was considered
satisfactory and the technical detailing presented may
contribute to new experiments.
The significant difference in grades attributed by
photos observed by examiners reveals the need to have
morphological knowledge of how fibers are presented by
immunofluorescence. Only one observer - a post-graduation
researcher- had opinions different from the others. Despite
this fact, none of the observers had any experience in
specific interpretation of human nasal mucosa. There were
three researchers that worked with immunelabeling of
neuropeptides in animal tissues, which in general contain
nerves, ganglions and cell bodies, presenting a different
pattern of labeling. The two others were taking post-
graduation studies, including the one whose interpretation
differed from the others. The interpretation of observer F,
or the author, was more completed considering that in
addition to the photos, he had observed the slides under
microscope, which inevitably presents the images with more
details, in addition to constituting a dynamic analysis.
Moreover, the author was the most involved observer, who
had theoretical conditions to interpret the images.
Individually, none of the 5 observers differed from the
author.
Considering these aspects, we deducted that the
method is reproducible in its interpretation of results
provided that there is familiarity with fiber labeling aspects
present in the nasal mucosa.
CONCLUSION
The immunofluorescence method proposed for VIP
in human nasal mucosa is sufficiently specific, sensitive and
reproducible, considered to be useful in investigations on
neuropeptides in human nasal mucosa.
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